Bicycle Therapeutics Plc Net Income

Bicycle Therapeutics Plc (BCYC) currently reports a net income of $-190M as of June 2026. That compares with $-240M in the prior-year period — up 21.4% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Bicycle Therapeutics Plc's net income history and peer comparisons.

Bicycle Therapeutics Plc's net income increased from $-240M to $-190M — a 21.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bicycle Therapeutics Plc's net income of $-190M is lower than the Healthcare sector average of $16B. That is roughly 101.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Bicycle Therapeutics Plc reported $-190M in net income as of June 2026. That compares with $-240M in the prior-year period — up 21.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-190M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Bicycle Therapeutics Plc, and consider following BCYC for alerts when major investors trade the stock.